Early morphologic and functional changes of atherosclerosis in systemic sclerosis-a systematic review and meta-analysis

Rheumatology (United Kingdom)

Volumn 55, Issue 12, 2016, Pages 2119-2130

  Meiszterics, Zsófia ^a   Tímár, Orsolya ^b   Gaszner, Balázs ^a   Faludi, Réka ^a   Kehl, Dániel ^a   Czirják, László ^a   Szücs, Gabriella ^b   Komócsi, András ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Ankle brachial index; Arterial stiffness; Augmentation index; Carotid intima media thickness; Flow mediated dilatation; Meta analysis; Nitroglycerine mediated dilatation; Pulse wave velocity; Scleroderma; Systemic sclerosis

Indexed keywords

GLYCERYL TRINITRATE; NITRATE;

ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; AUGMENTATION INDEX; DATA ANALYSIS SOFTWARE; DATA COLLECTION METHOD; DATA SYNTHESIS; DISEASE ASSOCIATION; DISEASE DURATION; FLOW-MEDIATED DILATION TEST; HEMODYNAMIC PARAMETERS; HUMAN; MEDLINE; META ANALYSIS; NOTE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSE WAVE; REGRESSION ANALYSIS; SYSTEMATIC REVIEW; SYSTEMIC SCLEROSIS; VASODILATATION; ARTERIAL STIFFNESS; BLOOD FLOW VELOCITY; COMPLICATION; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK ASSESSMENT;

ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; PULSE WAVE ANALYSIS; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; VASCULAR STIFFNESS; VASODILATION;

EID: 85020320427     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kew236     Document Type: Note

References (77)

1. Czirjak L, Pakozdi A, Kumanovics G, et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008;67:59-63.
2. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, et al. Mortality in systemic sclerosis: an international metaanalysis of individual patient data. Am J Med 2005;118:2-10.
3. Arias-Nunez MC, Llorca J, Vazquez-Rodriguez TR, et al. Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Medicine 2008;87:272-80.
4. Allanore Y, Avouac J, Kahan A. Systemic sclerosis: an update in 2008. Joint Bone Spine 2008;75:650-5.
5. Tyndall AJ, Bannert B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809-15.
6. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4.
7. Komocsi A, Vorobcsuk A, Faludi R, et al. The impact of cardio-pulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology 2012;51:1027-36.
8. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2013;72:1747-55.
9. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
10. Nussinovitch U, Shoenfeld Y. Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality. Autoimmun Rev 2011;10:259-66.
11. Ho M, Veale D, Eastmond C, Nuki G, Belch J. Macrovascular disease and systemic sclerosis. Ann Rheum Dis 2000;59:39-43.
12. Hettema ME, Zhang D, de Leeuw K, et al. Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors. Arthritis Res Ther 2008;10:R49.
13. Piccione MC, Bagnato G, Zito C, et al. Early identification of vascular damage in patients with systemic sclerosis. Angiology 2011;62:338-43.
14. Colaci M, Giuggioli D, Manfredi A, et al. Aortic pulse wave velocity measurement in systemic sclerosis patients. Reumatismo 2012;64:360-7.
15. Constans J, Germain C, Gosse P, et al. Arterial stiffness predicts severe progression in systemic sclerosis: the ERAMS study. J Hypertens 2007;25:1900-6.
16. Au K, Singh MK, Bodukam V, et al. Atherosclerosis in systemic sclerosis: a systematic review and metaanalysis. Arthritis Rheum 2011;63:2078-90.
17. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283: 2008-12.
18. Julian PT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley & Sons, 2008.
19. Lekakis J, Mavrikakis M, Papamichael C, et al. Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon. Am Heart J 1998;136:905-12.
20. Andersen GN, Mincheva-Nilsson L, Kazzam E, et al. Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production. Arthritis Rheum 2002;46:1324-32.
21. Cheng KS, Tiwari A, Boutin A, et al. Carotid and femoral arterial wall mechanics in scleroderma. Rheumatology 2003;42:1299-305.
22. Zakopoulos NA, Kotsis VT, Gialafos EJ, et al. Systemic sclerosis is not associated with clinical or ambulatory blood pressure. Clin Exp Rheumatol 2003;21:199-204.
23. Kawasaki M, Ito Y, Yokoyama H, et al. Assessment of arterial medial characteristics in human carotid arteries using integrated backscatter ultrasound and its histological implications. Atherosclerosis 2005;180:145-54.
24. Bartoli F, Blagojevic J, Bacci M, et al. Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis. Ann N Y Acad Sci 2007;1108:283-90.
25. Bartoli F, Angotti C, Fatini C, et al. Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. Rheumatology 2007;46:772-5.
26. D'Andrea A, Caso P, Cuomo S, et al. Myocardial and vascular dysfunction in systemic sclerosis: the potential role of noninvasive assessment in asymptomatic patients. Int J Cardiol 2007;121:298-301.
27. Kaloudi O, Basta G, Perfetto F, et al. Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. Rheumatology 2007;46:412-6.
28. Sherer Y, Cerinic MM, Bartoli F, et al. Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. Ann N Y Acad Sci 2007;1108:259-67.
29. Szučs G, Timar O, Szekanecz Z, et al. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis -relevance for prevention of vascular complications. Rheumatology 2007;46:759-62.
30. Cypiene A, Laucevicius A, Venalis A, et al. The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol 2008;27:1517-22.
31. Roustit M, Simmons GH, Baguet JP, Carpentier P, Cracowski JL. Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis. J Rheumatol 2008;35:1576-83.
32. Timar O, Soltesz P, Szamosi S, et al. Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol 2008;35:1329-33.
33. Peled N, Shitrit D, Fox BD, et al. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension. J Rheumatol 2009;36:970-5.
34. Mok MY, Yiu KH, Wong CY, et al. Low circulating level of CD133+KDR+cells in patients with systemic sclerosis. Clin Exp Rheumatol 2010;28(Suppl 62):S19-25.
35. Rollando D, Bezante GP, Sulli A, et al. Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment. J Rheumatol 2010;37:1168-73.
36. Rossi P, Granel B, Marziale D, Le Mée F, Frances Y. Endothelial function and hemodynamics in systemic sclerosis. Clin Physiol Funct Imaging 2010;30:453-9.
37. Tsifetaki N, Georgiadis AN, Alamanos Y, et al. Subclinical atherosclerosis in scleroderma patients. Scand J Rheumatol 2010;39:326-9.
38. Vettori S, Maresca L, Cuomo G, et al. Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previous corticosteroid treatment. Scand J Rheumatol 2010;39:485-9.
39. Liu J, Zhang Y, Cao TS, et al. Preferential macrovasculopathy in systemic sclerosis detected by regional pulse wave velocity from wave intensity analysis: comparisons of local and regional arterial stiffness parameters in cases and controls. Arthritis Care Res 2011;63:579-87.
40. Macedo R, Andretta M, Albers C, et al. Evaluation of carotid artery intima-media complex thickness as a marker of vascular damage secondary to accelerated atherogenesis in progressive systemic sclerosis. Rev Col Bras Cir 2012;39:10-5.
41. Zeng Y, Li M, Xu D, et al. Macrovascular involvement in systemic sclerosis: evidence of correlation with disease activity. Clin Exp Rheumatol 2012;30(Suppl 71):S76-80.
42. Nordin A, Jensen-Urstad K, Bjornadal L, et al. Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study. Arthritis Res Ther 2013;15:R87.
43. Sunbul M, Tigen K, Ozen G, et al. Evaluation of arterial stiffness and hemodynamics by oscillometric method in patients with systemic sclerosis. Wien Klin Wochenschr 2013;125:461-6.
44. Takahashi T, Asano Y, Amiya E, et al. Clinical correlation of brachial artery flow-mediated dilation in patients with systemic sclerosis. Mod Rheumatol 2014;24:106-11.
45. Turiel M, Gianturco L, Ricci C, et al. Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional study. Arthritis Care Res 2013;65:274-80.
46. Domsic RT, Dezfulian C, Shoushtari A, et al. Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients. Clin Exp Rheumatol 2014;32(Suppl 86):S154-60.
47. McKay ND, Griffiths B, Di Maria C, et al. Novel photoplethysmography cardiovascular assessments in patients with Raynaud's phenomenon and systemic sclerosis: a pilot study. Rheumatology 2014;53:1855-63.
48. Ngian GS, Sahhar J, Wicks IP, Van DS. Arterial stiffness is increased in systemic sclerosis: a cross-sectional comparison with matched controls. Clin Exp Rheumatol 2014;32(Suppl 86):S161-6.
49. Schiopu E, Au KM, McMahon MA, et al. Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a crosssectional, controlled study of carotid ultrasound. Rheumatology 2014;53:704-13.
50. Frech T, Walker AE, Barrett-O'Keefe Z, et al. Systemic sclerosis induces pronounced peripheral vascular dysfunction characterized by blunted peripheral vasoreactivity and endothelial dysfunction. Clin Rheumatol 2015;34:905-13.
51. Perk J, De BG, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33;1635-701.
52. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34;2159-219.
53. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94.
54. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22.
55. Man A, Zhu Y, Zhang Y, et al. The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis 2013;72:1188-93.
56. Polak JF, Szklo M, O'Leary DH. Associations of coronary heart disease with common carotid artery near and far wall intima-media thickness: the Multi-Ethnic Study of Atherosclerosis. J Am Soc Echocardiogr 2015;28:1114-21.
57. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65.
58. Yeboah J, Folsom AR, Burke GL, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009;120:502-9.
59. Yeboah J, Burke GL, Crouse JR, Herrington DM. Relationship between brachial flow-mediated dilation and carotid intima-media thickness in an elderly cohort: the Cardiovascular Health Study. Atherosclerosis 2008;197:840-5.
60. Herrick AL. Vascular function in systemic sclerosis. Curr Opin Rheumatol 2000;12:527-33.
61. Chung L, Shapiro L, Fiorentino D, et al. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial. Arthritis Rheum 2009;60:870-7.
62. Anderson ME, Moore TL, Hollis S, et al. Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis. Rheumatology 2002;41:324-8.
63. Roustit M, Blaise S, Allanore Y, et al. Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials. Ann Rheum Dis 2013;72:1696-9.
64. Tingey T, Shu J, Smuczek J, Pope J. Meta-analysis of healing and prevention of digital ulcers in systemic sclerosis. Arthritis Care Res 2013;65:1460-71.
65. Norman PE, Eikelboom JW, Hankey GJ. Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications. Med J Aust 2004;181:150-4.
66. McDermott MM, Greenland P, Liu K, et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med 2002;136:873-83.
67. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318-27.
68. Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010;121:505-11.
69. Komocsi A, Pinter T, Faludi R, et al. Overlap of coronary disease and pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 2010;69:202-5.
70. Kolto G, Faludi R, Aradi D, et al. Impact of cardiac involvement on the risk of mortality among patients with systemic sclerosis: a 5-year follow-up of a single-center cohort. Clin Rheumatol 2014;33:197-205.
71. Abou-Raya A, Abou-Raya S, Helmii M. Statins as immunomodulators in systemic sclerosis. Ann N Y Acad Sci 2007;1110:670-80.
72. Kuwana M, Okazaki Y, Kaburaki J. Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis. Mod Rheumatol 2009;19:530-5.
73. Sadik HY, Moore TL, Vail A, et al. Lack of effect of 8 weeks atorvastatin on microvascular endothelial function in patients with systemic sclerosis. Rheumatology 2010;49:990-6.
74. Rossi M, Bazzichi L, Ghiadoni L, et al. Increased finger skin vasoreactivity and stimulated vasomotion associated with simvastatin therapy in systemic sclerosis hypercholesterolemic patients. Rheumatol Int 2012;32:3715-21.
75. Timár O, Szekanecz Z, Kerekes G, Végh J, Oláh AV, Nagy G, Csiki Z, DankóK, Szamosi S, Németh A, Soltész P, Szučs G. Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis-a prospective case-series study. Arthritis Res Ther. 2013;15(5):R105.
76. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109:III27-32.
77. Khanna D, Kowal-Bielecka O, Khanna PP, et al. Quality indicator set for systemic sclerosis. Clin Exp Rheumatol 2011;29(Suppl 65):S33-9.